September 2, 2024 – LDEBIO is proud to announce that its innovative tuberculosis (TB) infection detection product, the AIMTB Mycobacterium Tuberculosis-Specific Cellular Immune Response Detection Kit (Fluorescence Immunochromatography), has successfully obtained the Class III Medical Device Registration Certificate from the National Medical Products Administration (NMPA).
